InsidersTradesSigma
Explore the full record of transactions filed by Kaplan Matthew L., Director. Insider active across 1 companies, notably Nuvectis Pharma, Inc.. Aggregated, 1 disclosures have been published. Total volume traded: €18k. The latest transaction was filed on 12 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
Matthew L. Kaplan is a Board Member at Nuvectis Pharma, Inc. In this role, he participates in the company's strategy and governance, ensuring that decisions align with shareholder objectives. His expertise is valuable for the company's development.